Clinical Trials Logo

Clinical Trial Summary

The CochlearTM Osia®2 System was cleared by the Food and Drug Administration November 15, 2019 (K191921) for individuals aged 12 years and older who present with conductive or mixed hearing loss (up to 55 dB HL) or single-sided-deafness (SSD).Published and unpublished data suggest significant pre to postoperative benefit and minimal risk in both children and adults who have received the Osia system. Thus the objective of this study is to examine the safety and effectiveness of the Cochlear Osia 2 system in a group of pediatric subjects aged 5 to 11 years who suffer from conductive or mixed hearing loss (up to 55 dB HL), or single-sided-deafness (SSD) with the intent of expanding the indications for use.


Clinical Trial Description

The CochlearTM Osia®2 System was cleared by the Food and Drug Administration November 15, 2019 (K191921) for individuals aged 12 years and older who present with conductive or mixed hearing loss (up to 55 dB HL) or single-sided-deafness (SSD). Published and unpublished data suggest significant pre to postoperative benefit and minimal risk in both children and adults who have received the Osia system. Due to the success of the Osia 2 system in the United States within the currently indicated patient population, clinical providers have since requested the ability to use the Osia 2 system in children aged 11 years and younger who meet the audiometric requirements. As the Osia 2 system is based on existing bone conduction and cochlear implant technologies which each possess a younger age of implantation requirement (5 years for bone conduction and 9 months for cochlear implantation), the current proposal is to align the age at implantation requirement with existing surgical bone conduction technology such as the Baha Connect and Baha Attract Systems to 5 years of age. Therefore, the objective of this study is to examine the safety and effectiveness of the Cochlear Osia 2 system in a group of pediatric subjects aged 5 to 11 years who suffer from conductive or mixed hearing loss (up to 55 dB HL), or single-sided-deafness (SSD) with the intent of expanding the indications for use. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05000931
Study type Interventional
Source Cochlear
Contact
Status Completed
Phase N/A
Start date January 26, 2022
Completion date March 14, 2024

See also
  Status Clinical Trial Phase
Completed NCT03723161 - Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
Completed NCT04320407 - Osia CPT Code Study N/A
Active, not recruiting NCT01445977 - SoundBite Hearing System Long Term Multi Site Patient Use Study N/A
Completed NCT02304692 - Clinical Survey of Different Abutment Topologies N/A
Recruiting NCT00393159 - The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children Phase 4
Recruiting NCT06164184 - Interest of the Cone Beam Scanner of Temporal Bones in the Analysis of Conductive Hearing Loss
Not yet recruiting NCT01967498 - Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study N/A
Active, not recruiting NCT05628285 - Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear N/A
Completed NCT03374787 - Evaluation of Sound Processor for a Transcutaneous System N/A
Completed NCT02092610 - Long Term Stability, Survival and Tolerability of a (Novel) Baha® Implant System N/A
Completed NCT01671176 - Wide Diameter Bone Anchored Implant Study N/A
Completed NCT03086135 - Clinical Performance of a New Implant System for Bone Conduction Hearing N/A
Recruiting NCT01807559 - SoundBite Hearing System 24 Month Multi Site Patient Use Study N/A
Withdrawn NCT01264510 - Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha) Phase 4
Recruiting NCT04803279 - Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear
Completed NCT03143257 - Ambispective Clinical Evaluation of Sophono™
Completed NCT02274129 - Clinical Survey of Oticon Medical Healing Cap N/A
Withdrawn NCT03541967 - Comparison of a New Bone Conduction Hearing System to a Osteo-integrated Bone Conduction Hearing Aid on a Softband N/A
Recruiting NCT03327194 - Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss N/A
Completed NCT03746548 - Audiological Benefit and Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Contact Mini N/A